Mr. Andrew has many years of experience and a track record in strategic management and business development. As head of Corporate Development at Santen Pharmaceutical Co., Ltd. and listed Chinese company Chengdu Kanghong Pharmaceutical Group Co., Ltd., he was responsible for business development, corporate planning, and product portfolio strategy, creating corporate value by leading pipeline out-licensing and in-licensing, business acquisitions, investment in biotech startups, and business reorganization.
Current role